Literature DB >> 7711365

Asymmetry of lumbar lateral flexion and treatment outcome in chronic low-back pain patients.

G Mellin1, K Härkäpää, H Hurri.   

Abstract

In a study on the treatment of chronic low-back pain (n = 456 patients; 58% men, 35-54 years of age), 3-month treatment outcome was assessed by back pain questionnaires and physical measurements including spinal and hip mobility and trunk muscle strength. Changes in differences between ranges of right and left lumbar lateral flexion and rotation of > 5 degrees from pretreatment to follow-up were recorded. A relative increase in left lumbar lateral flexion was associated with a better treatment outcome according to both back pain and physical performance (p < 0.05-0.001). With spinal rotation measurements no similar connections were observed. The results point to a connection between back pain and asymmetric spinal function, which may have pathogenetic and therapeutic significance.

Entities:  

Mesh:

Year:  1995        PMID: 7711365

Source DB:  PubMed          Journal:  J Spinal Disord        ISSN: 0895-0385


  4 in total

1.  Differences among outcome measures in occupational low back pain.

Authors:  Sue A Ferguson; William S Marras; Deborah L Burr
Journal:  J Occup Rehabil       Date:  2005-09

2.  Assessment of trunk lateral flexion range of movement using a novel method in first class cricket players.

Authors:  Andrew Nealon; Jill Cook; Sean Docking
Journal:  J Athl Train       Date:  2021-03-03       Impact factor: 2.860

3.  Manipulation Effect on Lumbar Kinematics in Patients with Unilateral Innominate Rotation and Comparison with Asymptomatic Subjects.

Authors:  Zamanlou M; Akbari M; Jamshidi A A; Amiri A; Nabiyouni I
Journal:  J Biomed Phys Eng       Date:  2019-06-01

4.  Predictive factors for successful non-operative treatment and achieving MCID improvement in health-related quality of life in adult spinal deformity.

Authors:  Jason Pui Yin Cheung; Hei Lung Wong; Prudence Wing Hang Cheung
Journal:  BMC Musculoskelet Disord       Date:  2022-08-22       Impact factor: 2.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.